Status:
COMPLETED
Evaluation of Analgesia by PENG Block Versus Intra-Articular Infiltration in Prosthetic Hip Surgery (API)
Lead Sponsor:
Ramsay Générale de Santé
Collaborating Sponsors:
European Clinical Trial Experts Network
Conditions:
Hip Prosthesis
Analgesia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of this study is to compare the effectiveness of the ultrasound-guided PENG block technique compared to intra-articular infiltration on postoperative morphine consumption during hip...
Eligibility Criteria
Inclusion
- Patient, male or female, over 18 years old.
- Patient scheduled for anterior hip prosthesis.
- Affiliated patient or beneficiary of a social security scheme.
- Patient having been informed and having signed a free and informed consent.
Exclusion
- Patient with a contraindication to local anesthesia.
- Patient with a high level of dependence, defined by level 1 or 2 of the Iso-Ressources Group (GIR).
- Patient participating in another clinical study.
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of freedom by judicial or administrative decision.
- Pregnant, breastfeeding or parturient woman.
- Patient hospitalized without consent.
Key Trial Info
Start Date :
March 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05250492
Start Date
March 2 2022
End Date
May 15 2023
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jean-François Oudet
Lanester, France, 56600